Glenmark's pain killer drug gets US FDA nod

摘要

Glenmark has said that the US-FDA has accepted its new drug application (NDA) for pain killer oxycodone hydrochloride capsules. The company had filed theNDA in order to be eligible for continued sales in the US to meet the criteria set by the health regulator.